UY29133A1 - AMIDAS CONTAINING (!! 2-TERT-BUTIL-1- (TETRAHIDRO-2H-PIRAN-4-ILMETIL) -1H-BENCIMIDAZOL-5- !!) (METHYL) AMINO! SULFONYL) AS SUBSTITUTE. PREPARATION PROCEDURE, COMPOSITIONS CONTAINING IT AND APPLICATIONS - Google Patents

AMIDAS CONTAINING (!! 2-TERT-BUTIL-1- (TETRAHIDRO-2H-PIRAN-4-ILMETIL) -1H-BENCIMIDAZOL-5- !!) (METHYL) AMINO! SULFONYL) AS SUBSTITUTE. PREPARATION PROCEDURE, COMPOSITIONS CONTAINING IT AND APPLICATIONS

Info

Publication number
UY29133A1
UY29133A1 UY29133A UY29133A UY29133A1 UY 29133 A1 UY29133 A1 UY 29133A1 UY 29133 A UY29133 A UY 29133A UY 29133 A UY29133 A UY 29133A UY 29133 A1 UY29133 A1 UY 29133A1
Authority
UY
Uruguay
Prior art keywords
bencimidazol
ilmetil
tetrahidro
amidas
butil
Prior art date
Application number
UY29133A
Other languages
Spanish (es)
Inventor
Walpole Christopher
Yang Hua
Page Daniel
Liu Ziping
Maxime C Tremblay
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/GB2004/004126 external-priority patent/WO2005030733A1/en
Priority claimed from PCT/GB2004/004112 external-priority patent/WO2005030761A1/en
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of UY29133A1 publication Critical patent/UY29133A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Psychology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Se prepararán compuestos de Fórmula I, o sales farmacéuticmente aceptables de los mismos: en donde R1, R2,R3,R4, R5, y G son como se definen en la memoria descriptiva así como sales y composiciones farmacéuticas que incluyen a los compuestos. son terapéuticamente útiles, en particular en el control del dolor.Compounds of Formula I, or pharmaceutically acceptable salts thereof, will be prepared: wherein R1, R2, R3, R4, R5, and G are as defined in the specification as well as salts and pharmaceutical compositions that include the compounds. They are therapeutically useful, particularly in pain control.

UY29133A 2004-09-24 2005-09-23 AMIDAS CONTAINING (!! 2-TERT-BUTIL-1- (TETRAHIDRO-2H-PIRAN-4-ILMETIL) -1H-BENCIMIDAZOL-5- !!) (METHYL) AMINO! SULFONYL) AS SUBSTITUTE. PREPARATION PROCEDURE, COMPOSITIONS CONTAINING IT AND APPLICATIONS UY29133A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/GB2004/004126 WO2005030733A1 (en) 2003-09-26 2004-09-24 Benzimidazole derivatives, compositions containing them, preparation therof and uses thereof
PCT/GB2004/004112 WO2005030761A1 (en) 2003-09-26 2004-09-24 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SE0500453 2005-02-28

Publications (1)

Publication Number Publication Date
UY29133A1 true UY29133A1 (en) 2006-04-28

Family

ID=36090308

Family Applications (1)

Application Number Title Priority Date Filing Date
UY29133A UY29133A1 (en) 2004-09-24 2005-09-23 AMIDAS CONTAINING (!! 2-TERT-BUTIL-1- (TETRAHIDRO-2H-PIRAN-4-ILMETIL) -1H-BENCIMIDAZOL-5- !!) (METHYL) AMINO! SULFONYL) AS SUBSTITUTE. PREPARATION PROCEDURE, COMPOSITIONS CONTAINING IT AND APPLICATIONS

Country Status (5)

Country Link
EP (1) EP1797075A1 (en)
JP (1) JP2008514591A (en)
AR (1) AR051448A1 (en)
UY (1) UY29133A1 (en)
WO (1) WO2006033629A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0302573D0 (en) 2003-09-26 2003-09-26 Astrazeneca Ab Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
BRPI0515897A (en) 2004-09-24 2008-08-12 Astrazeneca Ab compound, use thereof, pharmaceutical composition, and method for pain therapy in a warm-blooded animal, and for the preparation of a compound
TW200745049A (en) 2006-03-23 2007-12-16 Astrazeneca Ab New crystalline forms
TW200808769A (en) 2006-04-18 2008-02-16 Astrazeneca Ab Therapeutic compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0101387D0 (en) * 2001-04-20 2001-04-20 Astrazeneca Ab Novel compounds
SE0301701D0 (en) * 2003-06-10 2003-06-10 Astrazeneca Ab Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SE0302570D0 (en) * 2003-09-26 2003-09-26 Astrazeneca Ab Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SE0302571D0 (en) * 2003-09-26 2003-09-26 Astrazeneca Ab Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof

Also Published As

Publication number Publication date
JP2008514591A (en) 2008-05-08
WO2006033629A1 (en) 2006-03-30
AR051448A1 (en) 2007-01-17
EP1797075A1 (en) 2007-06-20

Similar Documents

Publication Publication Date Title
UY30316A1 (en) SUBSTITUTED DERIVATIVES OF BENZAMIDS, NICOTINAMIDS, PROPANAMIDS, ACETAMIDS AND CARBOXAMIDS N- (2- (PIPERIDIN-1-ILMETIL) CICLOHEXIL) REPLACED, PREPARATION PROCESSES, COMPOSITIONS CONTAINING AND APPLICATIONS
UY29427A1 (en) SUBSTITUTED DERIVATIVES OF 2,3,4,5- TETRAHIDRO-1H-PIRIDO (4,3-B) INDOL, COMPOSITIONS CONTAINING THEM, PREPARATION PROCESSES AND APPLICATIONS
UY31334A1 (en) 3A, 4,5,6,7,7A-HEXAHIDRO-3H-BENZOIMIDAZOL AND DERIVAODS OF 3A, 4,5,6,, 7,7A-HEXAHIDRO-3-INDOL, ENANTIOMERS, DIASTEREOISOMERS, PHARMACEUTICALLY ACCEPTED SALTS, MIXTURES, COMPOSITIONS , PREPARATIONS AND APPLICATIONS OF THE SAME
PE20090816A1 (en) PYRROLOPYRIMIDINONE DERIVATIVES AS BINDING AGENTS OF P2X3 RECEPTORS
CY1116103T1 (en) Substituted 1,2,3,4-tetrahydroisoquinoline derivatives
UY30393A1 (en) SUBSTITUTED DERIVATIVES OF 1-PIPERIDIN-1-IL-1,3-DIHIDRO-2H-BENZIMIDAZOL-2-ONA, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, PREPARATION PROCESSES AND APPLICATIONS
UY29963A1 (en) THERAPEUTIC COMPOUNDS: PIRIDINES AND PIRAZINAS AS ANDAMIOS
GT200600518A (en) PIRIMIDINE DERIVATIVES
UY30206A1 (en) DIAMINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, PREPARATION PROCESSES AND APPLICATIONS
UY28923A1 (en) THERAPEUTIC COMPOUNDS: PYRIDINE AS A BASE STRUCTURE
SE0401342D0 (en) Therapeutic compounds
BRPI0618479A2 (en) pyrrolpyridines pharmaceutical composition containing them
UY28536A1 (en) DERIVATIVES OF BENCIMIDAZOL, COMPOSITIONS THAT CONTAIN THEM, PREPARATION AND USES OF THE SAME.
UY30397A1 (en) SUBSTITUTED DERIVATIVES OF THE (3AS, 7AS) -1,3A, 4,5,6,7-HEXAHIDRO-3H-BENZOIMIDAZOL-2-ONA, PREPARATION PROCESS, COMPOSITIONS CONTAINING AND APPLICATIONS
UY30363A1 (en) SUBSTITUTED DERIVATIVES OF THE N- (3-OXO-2,3-DIHIDRO-1H-ISOINDOL-4-IL) -1-NAFTAMIDE, PREPARATION PROCESSES, PHARMACEUTICAL COMPOSITIONS AND APPLICATIONS
UY30289A1 (en) DERIVATIVES OF 1H-PIRROL-3-CARBOXAMIDE REPLACED WITH 1- (TETRAHIDRO-2H-PIRAN-4-IL-METIL) -1H-BENCIMIDAZOL, COMPOSITIONS CONTAINING THEM, PREPARATION PROCEDURES AND APPLICATIONS
UY28356A1 (en) DERIVATIVES OF BENZIMIDAZOL, COMPOSITIONS THAT CONTAIN THEM, PREPARATIONS OF THE SAME AND ITS USES
UY29234A1 (en) ADAMANTAN DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, BOTH PREPARATION PROCEDURES AND APPLICATIONS.
UY28357A1 (en) DERIVATIVES OF BENZIMIDAZOL, COMPOSITIONS THAT CONTAIN THEM, PREPARATION OF THE SAME AND ITS USES
UY30001A1 (en) QUINOLIN ALQUILSULFONAMIDE
UY29804A1 (en) ALQUILNITRILO QUINOLINS
UY29134A1 (en) SULFONAMIDS REPLACED BY BENCIMIDAZOL DERIVATIVES, COMPOSITIONS THAT CONTAIN IT, PREPARATION PROCEDURE AND APPLICATIONS
UY28535A1 (en) DERIVATIVES OF BENCIMIDAZOL, COMPOSITIONS THAT CONTAIN THEM, PREPARATION AND USES OF THE SAME.
CR10210A (en) BENZOISOINDOL DERIVATIVES FOR PAIN TREATMENT
UY28537A1 (en) DERIVATIVES OF BENCIMIDAZOL, COMPOSITIONS THAT CONTAIN THEM, PREPARATION AND USES OF THE SAME.

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20160601